Tachyphylaxis during ranibizumab treatment of exudative age-related macular degeneration

被引：0
|
作者：
Sibel Doguizi [1 ]
Sengul Ozdek [2 ]
Selcen Yuksel [3 ]
机构：
[1] Department of Ophthalmology, Dogubeyazit State Hospital
[2] Department of Ophthalmology, Faculty of Medicine, Gazi University
[3] Faculty of Medicine Biostatistics Department, Yildirim Beyazit University
来源：
International Journal of Ophthalmology | 2015年 / 04期
关键词：
CNV;
D O I：
暂无
中图分类号：
R774.5 [黄斑、中心窝疾病];
学科分类号：
100212 ;
摘要：
Dear Editor,We are intestigators from Turkey primarily studying exudative age-related macular degeneration(AMD).Here we present the results of our retrospective clinical study on tachyphylaxis development during the treatment of exudative AMD with ranibizumab,which,we believe,will form a basis for further prospective studies to predict the drug response in anti-vascular endothelial growth factor
引用
收藏
页码：846 / 848
页数：3
相关论文
共 50 条
  • [1] Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab
    Eghoj, Maria Salling
    Sorensen, Torben Lykke
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2012, 96 (01) : 21 - 23
  • [2] Tachyphylaxis during ranibizumab treatment of exudative age-related macular degeneration
    Doguizi, Sibel
    Ozdek, Sengul
    Yuksel, Selcen
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2015, 8 (04) : 846 - 848
  • [3] Tachyphylaxis during treatment of exudative age-related macular degeneration with aflibercept
    Hara, Chikako
    Wakabayashi, Taku
    Fukushima, Yoko
    Sayanagi, Kaori
    Kawasaki, Ryo
    Sato, Shigeru
    Sakaguchi, Hirokazu
    Nishida, Kohji
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (11) : 2559 - 2569
  • [4] Tachyphylaxis during treatment of exudative age-related macular degeneration with aflibercept
    Chikako Hara
    Taku Wakabayashi
    Yoko Fukushima
    Kaori Sayanagi
    Ryo Kawasaki
    Shigeru Sato
    Hirokazu Sakaguchi
    Kohji Nishida
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 2559 - 2569
  • [5] Bimonthly Ranibizumab for Exudative Age-related Macular Degeneration
    Cohen, Salomon
    Maloberti, Bertrand
    Fajnkuchen, Franck
    Nghiem-Buffet, Sylvia
    Delahaye-Mazza, Corinne
    Grenet, Typhaine
    Quentel, Gabriel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [6] Results of Intravitreal Ranibizumab Treatment for Exudative Age-Related Macular Degeneration
    Karaca, Umut
    Durukan, Ali Hakan
    Erdurman, Fazil Cuneyt
    Sobaci, Gungor
    Bayraktar, Mehmet Zeki
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2012, 42 (01): : 25 - 29
  • [7] Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration
    Gamulescu M.-A.
    Radeck V.
    Lustinger B.
    Bianca Fink B.
    Helbig H.
    International Ophthalmology, 2010, 30 (3) : 261 - 266
  • [8] Efficacy of aflibercept on exudative age-related macular degeneration in patients exhibiting complete ranibizumab resistance and tachyphylaxis
    Gokce, Gokcen
    Durukan, Ali Hakan
    Koylu, Mehmet Talay
    Kucukevcilioglu, Murat
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2016, 79 (06) : 384 - 389
  • [9] DELAY IN RANIBIZUMAB INJECTIONS FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Wang, Bob
    Lake, Stewart
    Saha, Niladri
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 38 : 8 - +
  • [10] TACHYPHYLAXIS AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Forooghian, Farzin
    Cukras, Catherine
    Meyerle, Catherine B.
    Chew, Emily Y.
    Wong, Wai T.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (06): : 723 - 731
12345